<table id="_Refid_10e02529-22c2-4e8d-96ca-305341502" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table I.  Mean and range of total body clearance and half-life of theophylline related to age and altered physiological states.<footnote id="_Refid-6fb32510-a6b4-4f63-a9e7-a07552dc0">For various North American patient populations from literature reports. Different rates of elimination and consequent dosage requirements have been observed among other peoples.</footnote>
</caption>
<col width="41%"></col>
<col width="24%"></col>
<col width="19%"></col>
<tbody>
<tr>
<td stylecode="Toprule ">
<paragraph>
<content stylecode="bold">Population Characteristics</content>
</paragraph>
<paragraph>
<content stylecode="bold">
<content stylecode="italics">
<content stylecode="underline">Age </content>
</content>
</content>
</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>
<content stylecode="bold">Total body clearance</content>
<footnote id="_Ref396743910">Clearance represents the volume of blood completely cleared of theophylline by the liver in one minute. Values listed were generally determined at serum theophylline concentrations &lt;20 mcg/mL; clearance may decrease and half-life may increase at higher serum concentrations due to non-linear pharmacokinetics. </footnote>
</paragraph>
<paragraph>
<content stylecode="bold">mean (range)</content>
<footnote id="_Refid-5cfd54a4-e164-4f5c-ac17-85abb855a">Reported range or estimated range (mean +/- 2 SD) where actual range not reported.</footnote>
</paragraph>
<paragraph>
<content stylecode="bold">
<content stylecode="underline">(mL/kg/min)</content>
</content>
</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>
<content stylecode="bold">Half-life</content>
</paragraph>
<paragraph>
<content stylecode="bold">mean (range)</content>
<footnoteref idref="_Refid-5cfd54a4-e164-4f5c-ac17-85abb855a"></footnoteref>
</paragraph>
<paragraph>
<content stylecode="bold">
<content stylecode="underline">(hr)</content>
</content>
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Premature neonates</paragraph>
<paragraph>     postnatal age 3 to 15 days</paragraph>
<paragraph>     postnatal age 25 to 57 days</paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph>0.29 (0.09 to 0.49)</paragraph>
<paragraph>0.64 (0.04 to 1.2)</paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph>30 (17 to 43)</paragraph>
<paragraph>20 (9.4 to 30.6)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Term infants </paragraph>
<paragraph>     postnatal age 1 to 2 days</paragraph>
<paragraph>     postnatal age 3 to 30 weeks</paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph>NR<footnote id="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7">NR = not reported or not reported in a comparable format.</footnote>
</paragraph>
<paragraph>NR<footnoteref idref="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7"></footnoteref>
</paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph>25.7 (25 to 26.5)</paragraph>
<paragraph>11 (6 to 29)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Children</paragraph>
<paragraph>     1 to 4 years</paragraph>
<paragraph>     4 to 12 years</paragraph>
<paragraph>     13 to 15 years</paragraph>
<paragraph>     6 to 17 years</paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph>1.7 (0.5 to 2.9)</paragraph>
<paragraph>1.6 (0.8 to 2.4)</paragraph>
<paragraph>0.9 (0.48 to 1.3)</paragraph>
<paragraph>1.4 (0.2 to 2.6)</paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph>3.4 (1.2 to 5.6)</paragraph>
<paragraph>NR<footnoteref idref="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7"></footnoteref>
</paragraph>
<paragraph>NR<footnoteref idref="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7"></footnoteref>
</paragraph>
<paragraph>3.7 (1.5 to 5.9)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Adults (16 to 60 years)</paragraph>
<paragraph>     otherwise healthy</paragraph>
<paragraph>     nonsmoking asthmatics </paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph>0.65 (0.27 to 1.03) </paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph>8.7 (6.1 to 12.8)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Elderly (&gt;60 years)</paragraph>
<paragraph>     nonsmokers with normal cardiac,</paragraph>
<paragraph>     liver, and renal function</paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph>0.41 (0.21 to 0.61)</paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph>9.8 (1.6 to 18) </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<content stylecode="bold">
<content stylecode="italics">Concurrent illness or</content>
</content>
</paragraph>
<paragraph>
<content stylecode="bold">
<content stylecode="italics">
<content stylecode="underline">altered physiological state</content>
</content>
</content>
</paragraph>
</td>
<td></td>
<td></td>
</tr>
<tr>
<td>
<paragraph>Acute pulmonary edema </paragraph>
</td>
<td>
<paragraph>0.33<footnote id="_Refid-f7951838-a7bf-4f46-bd55-5601e776b">Median.</footnote> (0.07 to 2.45) </paragraph>
</td>
<td>
<paragraph>19<footnoteref idref="_Refid-f7951838-a7bf-4f46-bd55-5601e776b"></footnoteref> (3.1 to 82)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>COPD-&gt;60 years, stable</paragraph>
<paragraph>     nonsmoker &gt; 1 year </paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph>0.54 (0.44 to 0.64) </paragraph>
</td>
<td>
<paragraph> </paragraph>
<paragraph>11 (9.4 to 12.6)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>COPD with cor pulmonale </paragraph>
</td>
<td>
<paragraph>0.48 (0.08 to 0.88) </paragraph>
</td>
<td>
<paragraph>NR<footnoteref idref="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Cystic fibrosis (14 to 28 years) </paragraph>
<paragraph>Fever associated with acute viral<br/>respiratory illness (children 9 to 15 years)</paragraph>
</td>
<td>
<paragraph>1.25 (0.31 to 2.2) </paragraph>
<paragraph> </paragraph>
<paragraph>NR<footnoteref idref="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7"></footnoteref>
</paragraph>
</td>
<td>
<paragraph>6.0 (1.8 to 10.2)</paragraph>
<paragraph> </paragraph>
<paragraph>7.0 (1.0 to 13)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Liver disease - cirrhosis </paragraph>
<paragraph>                         acute hepatitis </paragraph>
<paragraph>                         cholestasis </paragraph>
</td>
<td>
<paragraph>
<br/>0.31<footnoteref idref="_Refid-f7951838-a7bf-4f46-bd55-5601e776b"></footnoteref> (0.1 to 0.7)</paragraph>
<paragraph>0.35 (0.25 to 0.45)</paragraph>
<paragraph>0.65 (0.25 to 1.45) </paragraph>
</td>
<td>
<paragraph>
<br/>32<footnoteref idref="_Refid-f7951838-a7bf-4f46-bd55-5601e776b"></footnoteref> (10 to 56)</paragraph>
<paragraph>19.2 (16.6 to 21.8)</paragraph>
<paragraph>14.4 (5.7 to 31.8) </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Pregnancy - 1st trimester</paragraph>
<paragraph>                    2nd trimester</paragraph>
<paragraph>                    3rd trimester</paragraph>
</td>
<td>
<paragraph>
<br/>NR<footnoteref idref="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7"></footnoteref>
</paragraph>
<paragraph>NR<footnoteref idref="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7"></footnoteref>
</paragraph>
<paragraph>NR<footnoteref idref="_Refid-f9e75d62-c03d-43ad-b6a4-6774e6fd7"></footnoteref>
</paragraph>
</td>
<td>
<paragraph>
<br/>8.5 (3.1 to 13.9) </paragraph>
<paragraph>8.8 (3.8 to 13.8)</paragraph>
<paragraph>13.0 (8.4 to 17.6)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Sepsis with multi-organ failure </paragraph>
<paragraph> Thyroid disease     - hypothyroid</paragraph>
<paragraph>                                 hyperthyroid</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>0.47 (0.19 to 1.9) </paragraph>
<paragraph>0.38 (0.13 to 0.57)</paragraph>
<paragraph>0.8 (0.68 to 0.97) </paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>18.8 (6.3 to 24.1)</paragraph>
<paragraph>11.6 (8.2 to 25)</paragraph>
<paragraph>4.5 (3.7 to 5.6)</paragraph>
</td>
</tr>
</tbody>
</table>